REUTERS: The U.S. Food and Drug Administration on Tuesday declined to approve Nabriva Therapeutics Plc's antibiotic for complicated urinary tract infections (cUTI), even as the nation grapples with the growing problem of antibiotic resistance. Nabriva's Contepo, chemically known as fosfomycin, is ...
from Latest News http://bit.ly/2WiNZI6
FDA declines to approve Nabriva's antibiotic for urinary tract infections
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment